Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 7N03P021J8

Structure

InChI Key JCINBYQJBYJGDM-UHFFFAOYSA-N
Smile CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21
InChI
InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H28N8O
Molecular Weight 432.53
AlogP 3.5
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 6.0
Polar Surface Area 85.8
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 32.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tyrosine-protein kinase JAK2 inhibitor PubMed PubMed
Primary Target
Janus kinase 2

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 1271022-90-2
ChEMBL CHEMBL3545215
DrugBank DB12591
EPA CompTox DTXSID00155403
FDA SRS 7N03P021J8
Guide to Pharmacology 7954
PDB 50V
PubChem 50922691
SureChEMBL SCHEMBL1512419
ZINC ZINC000100468481